Clinical Trials Browser

OTHER × Hematologic Diseases × 90 days × Clear all

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT05032820 2026-05-19

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

Phase 2 Completed

40 enrolled 32 charts

Plasma cell

Hematologic Diseases, Multiple Myeloma

NCT03246906 2026-05-14

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Phase 2 Terminated

150 enrolled 18 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT04202094 2026-05-06

Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

Phase NA Enrolling by invitation

50 enrolled

Hematologic Diseases, Neoplasms

NCT05833438 2026-05-01

VENAZA-5S

Phase 2 Active not recruiting

45 enrolled

Other hematologic neoplasm

Hematologic Diseases, Leukemia, Myeloid, Acute

NCT05414045 2026-04-23

Autologous Testicular Tissue Transplantation

Phase NA Recruiting

5 enrolled

Hematologic Diseases, Neoplasms

NCT07541326 2026-04-21

COMPLHEMATO

Phase NA Not yet recruiting

85 enrolled

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT03030248 2026-04-15

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Phase 2 Completed

9 enrolled 9 charts

Clostridium Infections, Hematologic Diseases

NCT03207854 2026-04-02

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Recruiting

625 enrolled

Other hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Neoplasms, Hematologic Neoplasms

NCT05969821 2026-03-23

CHIS

Not yet recruiting

5,000 enrolled

LymphoidMyeloidOther hematologic neoplasm

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT07387354 2026-03-16

MDS

Phase 1/2 Not yet recruiting

25 enrolled

Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

Clinical Trials

Therapeutic RSK1 Targeting in Myelofibrosis

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

VENAZA-5S

Autologous Testicular Tissue Transplantation

COMPLHEMATO

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

CHIS

MDS